24/7 Market News Snapshot 26 December, 2024 – Hoth Therapeutics, Inc. Common Stock (NASDAQ:HOTH)

December 26, 2024

DENVER, Colo., 26 December, 2024 (247marketnews.com) – (NASDAQ:HOTH) are discussed in this article.
Hoth Therapeutics, Inc. (NASDAQ:HOTH), a biopharmaceutical leader focused on innovative therapies, has recently signed an exclusive patent license agreement with the U.S. Department of Veterans Affairs (VA) in collaboration with Emory University. This pivotal agreement grants Hoth exclusive rights to a patent portfolio centered on addressing obesity and related health issues through Glial Cell Line-Derived Neurotrophic Factor technology. Robb Knie, CEO of Hoth Therapeutics, remarked on the significance of this partnership, emphasizing the company’s commitment to advancing impactful healthcare solutions.

The deal allows Hoth to develop, market, and commercialize products based on this groundbreaking technology, aiming to increase accessibility to crucial innovations in obesity treatment. This advancement underscores Hoth’s strategic initiative to expand its intellectual property and research capabilities. In line with this goal, the company has also entered into a Letter of Intent (LOI) to secure additional provisional patent protection for its leading therapeutic, HT-001, which extends Hoth’s reach into cancer therapeutics.

Simultaneously, Hoth’s stock opened at $0.81 but has seen a decrease to $0.77, reflecting a decline of approximately 2.16%. With the previous close at $0.787, the market shows signs of bearish sentiment, creating a need for traders to look for support around $0.75, an area that may provide an opportunity for a rebound amid high trading volume of 8.19 million shares.

As Hoth Therapeutics moves forward with this groundbreaking agreement and actively seeks to enhance its portfolio, the company remains committed to bringing innovative therapies from the research phase to market, ultimately improving patient outcomes and addressing significant healthcare challenges.

Related news for (HOTH)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.